FFVAX | TRUBX | FFVAX / TRUBX | |
Total Expense Ratio | 0.77 | 0.35 | 220% |
Annual Report Gross Expense Ratio | 0.77 | 0.35 | 220% |
Fund Existence | 22 years | 2 years | - |
Gain YTD | 2.691 | 4.061 | 66% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 0 | 500000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 430M | 5.17B | 8% |
Annual Yield % from dividends | 2.48 | 2.95 | 84% |
Returns for 1 year | 3.64 | 6.40 | 57% |
Returns for 3 years | 18.53 | N/A | - |
Returns for 5 years | 3.88 | N/A | - |
Returns for 10 years | -2.37 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FGSAX | 61.70 | N/A | N/A |
Federated Hermes MDT Mid Cap Growth A | |||
AMEFX | 26.17 | N/A | N/A |
American Funds Income Fund of Amer F2 | |||
NCVLX | 11.85 | N/A | N/A |
Nuance Concentrated Value Institutional | |||
MSMFX | 14.93 | N/A | N/A |
Morgan Stanley Inst Discovery C | |||
FEFRX | 28.58 | -0.01 | -0.03% |
First Eagle Rising Dividend Fund R6 |